4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Hematology: new trials by email Literature Review of Hematology trials Research Report on Hematology
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC KM-001 cream 1% 12 weeks treatment., Physical Examination, Vital Signs - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita | Phase 1 | Completed | Orvida Pharma (formerly Kamari Pharma) | 18 | 2023-03-06 | 2025-01-15 |
| Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases Serum chemistry, Hematology, Urinalysis - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita | Phase 1 | Completed | Orvida Pharma (formerly Kamari Pharma) | 14 | 2022-07-17 | 2025-01-07 |
| KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC) IMP Application KM-001, Chemistry, Hematology - Lichen Simplex Chronicus | Phase 1 | Completed | Orvida Pharma (formerly Kamari Pharma) | 55 | 2022-05-24 | 2024-04-02 |
| Anthrax Vaccine Clinical Trials Anthrax Vaccine, Blood Chemistry, Hematology - Anthrax | Phase 1 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 93 | 2004-09-08 | 2017-07-02 |
Keratosis palmoplantaris papulosa (2) · Pachyonychia Congenita (2) · Anthrax (1) · Neurodermatitis (1)
Orvida Pharma (formerly Kamari Pharma) (3) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)
Germany (1) · Israel (1) · United Kingdom (1) · United States (1)